Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-donor alloreactivity-guided tacrolimus minimization in living-donor kidney transplantation
2015-002465-28Phase 4Completed
- Sponsor
- LMU Klinikum
- Start
- Nov 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tacrolimus in kidney allograft rejection (2 arms), sponsored by LMU Klinikum. Primary endpoint: Renal function (MDRD-4 estimated GFR). Started Nov 2015; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2015-002465-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002465-28.